Sort   by:  
 Page size 
UnknownSARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
Not available
S-EPMC7646625 | biostudies-literature
UnknownBamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Not available
S-EPMC8314785 | biostudies-literature
UnknownCyclometalated Iridium-PhanePhos Complexes Are Active Catalysts in Enantioselective Allene-Fluoral Reductive Coupling and Related Alcohol-Mediated Carbonyl Additions That Form Acyclic Quaternary Carbon Stereocenters.
Not available
S-EPMC6423978 | biostudies-literature
UnknownA Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors.
Not available
S-EPMC10769797 | biostudies-literature
UnknownRamucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial.
Not available
S-EPMC7360144 | biostudies-literature
UnknownClinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy.
Not available
S-EPMC5548297 | biostudies-literature
UnknownPrediction and Classification of Alzheimer's Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers.
Not available
S-EPMC6805777 | biostudies-literature
UnknownMulti-Site N-glycan mapping study 1: Capillary electrophoresis - laser induced fluorescence.
Not available
S-EPMC4966509 | biostudies-literature
UnknownTrial of Solanezumab in Preclinical Alzheimer's Disease.
Not available
S-EPMC10559996 | biostudies-literature
UnknownAlzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.
Not available
S-EPMC5696639 | biostudies-literature
Sort   by:  
 Page size